In the fast-paced landscape of mRNA medicine development, transitioning quickly from sequence design to functional testing is critical . Traditional workflows are frequently bottlenecked by the slow, labor-intensive, and error-prone process of adding a poly(A) tail during PCR amplification .

Discover how Australia’s leading BASE mRNA Facility— supported by The University of Queensland and Therapeutics Innovation Australia—successfully validated a cell-free, high-fidelity alternative that eliminates this workflow bottleneck .

This comprehensive case study demonstrates how Elegen’s ENFINIA™ IVT Ready DNA delivers a streamlined, ready-to-use solution for in vitro transcription (IVT) . By using linear DNA templates with pre-encoded poly(A) tails, researchers can entirely bypass traditional PCR tailing steps and significantly shorten experimental timelines .

What You’ll Learn:

• Workflow Optimization: How to eliminate labor-intensive preparation steps and move directly from DNA receipt to immediate mRNA synthesis .

• Head-to-Head Benchmarking: Rigorous data comparing ENFINIA to standard PCR-amplified templates across diverse genes (including eGFP, fLuc, and SARS-CoV-2 Spike) .

• Uncompromised CQAs: Proof that ENFINIA templates match conventional methods in Critical Quality Attributes, achieving equivalent mRNA yield, chemical purity, structural integrity, and cellular protein expression .